Neurizon Therapeutics 

A$0.2
0
+A$0+0% Hari ini

Statistik

Harga Tertinggi Hari Ini
0.21
Harga Terendah Hari Ini
0.2
52M Tinggi
0.25
52M Rendah
0.19
Volume
754,038
Rata-Rata Volume
814,348
Kap Pasar
-
Rasio P/E
-
Hasil Dividen
-
Dividen
-

Orang Juga Mengikuti

Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti NUZ.AU. Ini bukan rekomendasi investasi.

Peserta

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

PharmAust Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. PharmAust Limited was incorporated in 2000 and is based in Melbourne, Australia.
Show more...
CEO
Dr. Michael Thurn Ph.D.
Negara
AU
ISIN
AU0000357261

Daftar